Allergy Therapeutics Financial Statements 2016-2025 | AGYTF

Fifteen years of historical annual and quarterly income statements for Allergy Therapeutics (AGYTF).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM202420232022202120202019201820172016
$0.00$69.52$71.77$96.86$118$98.60$95.40$92.06$81.35$71.98
$0.00$32.07$31.73$30.96$30.90$25.47$23.78$22.92$21.27$20.88
$0.00$37.45$40.04$65.90$86.98$73.13$71.61$69.15$60.08$51.10
$0.00$28.84$24.24$20.84$18.01$7.37$8.99$21.57$11.79$24.07
$0.00$53.37$58.88$62.34$64.12$56.08$57.70$57.48$51.58$44.99
$0.00$0.36$-4.69$0.99$0.79$0.80$0.77$0.85$0.89$0.22
$0.00$81.85$87.81$82.20$81.34$62.65$65.93$78.21$62.48$68.84
$0.00$-44.40$-47.76$-16.30$5.63$10.48$5.68$-9.07$-2.40$-17.73
$0.00$-4.92$-2.54$-0.55$-0.52$-0.30$-0.13$-0.22$-0.09$-0.17
$0.00$-49.33$-50.31$-16.85$5.11$10.18$5.56$-9.29$-2.50$-17.90
$0.00$1.32$1.57$1.49$1.08$1.28$1.07$0.86$0.65$1.50
$0.00$-50.65$-51.88$-18.34$4.03$8.90$4.49$-10.15$-3.15$-19.40
$0.00$0$0$0$0$0$0$0$0$0
$0.00$-50.65$-51.88$-18.34$4.03$8.90$4.49$-10.15$-3.15$-19.40
$0.00$0$0$0$0$0$0$0$0$0
$0.00$-50.65$-51.88$-18.34$4.03$8.90$4.49$-10.15$-3.15$-19.40
$0.00$-38.96$-42.68$-10.75$11.41$15.41$8.39$-6.34$0.05$-15.26
$0.00$-44.40$-47.76$-16.30$5.63$10.48$5.68$-9.07$-2.40$-17.73
$0.00$-0.01$-0.08$-0.03$0.01$0.01$0.01$-0.02$-0.01$-0.03
$0.00$-0.01$-0.08$-0.03$0.01$0.01$0.01$-0.02$-0.01$-0.03

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-06-302023-12-312023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312020-06-302019-12-312019-06-302018-06-302017-12-312017-06-302016-12-312016-06-30
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00